工作是为了生存,工作是为了生存.

D McNamee

Lancet (London, England)

|April 16, 1994

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

New drug classes 2001.

Lancet (London, England)·2001

Same author

Tackling venomous snake bites worldwide.

Lancet (London, England)·2001

Same author

Review of clinical protocols at The Lancet.

Lancet (London, England)·2001

Same author

Cancer paper retracted.

Lancet (London, England)·2001

Same author

Pies flying low in a blue sky.

Lancet (London, England)·2000

Same author

Ovarian-cancer results cause a stir at cancer conference.

Lancet (London, England)·2000

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

工作是为了生存,工作是为了生存.

相关概念视频

New drug classes 2001.

Tackling venomous snake bites worldwide.

Review of clinical protocols at The Lancet.

Cancer paper retracted.

Pies flying low in a blue sky.

Ovarian-cancer results cause a stir at cancer conference.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

工作是为了生存,工作是为了生存.

相关概念视频

New drug classes 2001.

Tackling venomous snake bites worldwide.

Review of clinical protocols at The Lancet.

Cancer paper retracted.

Pies flying low in a blue sky.

Ovarian-cancer results cause a stir at cancer conference.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.